Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | UPB | AZN | AMGN | GILD | VRTX |
| Company | Upstream Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 7.51 | 205.64 | 388.86 | 147.87 | 496.60 |
| High | 7.92 | 206.19 | 390.88 | 150.20 | 498.03 |
| Low | 7.51 | 204.78 | 387.10 | 147.80 | 492.07 |
| Latest | 7.53 | 205.84 | 391.12 | 149.87 | 490.75 |
| Change | -0.15 | -2.61 | +2.96 | +0.92 | -6.08 |
| % Change | -1.95% | -1.25% | +0.76% | +0.62% | -1.22% |
| Volume | 143,267 | 254,524 | 18,340 | 502,123 | 66,812 |
| 20-Day Average Volume | 2,266,129 | 2,425,222 | 2,895,130 | 7,519,739 | 1,452,574 |
| Previous Close | 7.68 | 208.45 | 388.16 | 148.95 | 496.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.63 | 200.14 | 372.47 | 149.66 | 475.72 |
| 20-Day Raw Stochastic | 0.50% | 75.21% | 95.57% | 56.02% | 82.57% |
| 20-Day Relative Strength | 23.52 | 59.86 | 65.42 | 59.22 | 59.45 |
| Weighted Alpha | +60.63 | +41.80 | +31.39 | +38.00 | +10.05 |
| Today's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.87% since 02/23/26 | +0.27% since 02/23/26 | +2.22% since 02/23/26 | -0.09% since 02/23/26 | +2.96% since 02/23/26 |
| Low | 7.59 on 03/02/26 | 202.64 on 02/26/26 | 374.25 on 02/26/26 | 143.09 on 02/26/26 | 474.59 on 02/26/26 |
| High | 8.32 on 02/26/26 | 209.93 on 02/27/26 | 390.14 on 02/27/26 | 150.08 on 02/24/26 | 498.02 on 03/02/26 |
| 1-Month | |||||
| %Chg | -74.25% since 02/02/26 | +9.07% since 02/02/26 | +12.53% since 02/02/26 | +4.76% since 02/02/26 | +4.92% since 02/02/26 |
| Low | 7.59 on 03/02/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 454.40 on 02/11/26 |
| High | 31.05 on 02/03/26 | 212.71 on 02/18/26 | 390.14 on 02/27/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -69.17% since 12/02/25 | +13.95% since 12/02/25 | +14.63% since 12/02/25 | +20.81% since 12/02/25 | +14.34% since 12/02/25 |
| Low | 7.59 on 03/02/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 33.68 on 01/14/26 | 212.71 on 02/18/26 | 390.14 on 02/27/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | -61.94% since 09/02/25 | +28.13% since 09/02/25 | +35.18% since 09/02/25 | +32.81% since 09/02/25 | +23.50% since 09/02/25 |
| Low | 7.59 on 03/02/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 33.68 on 01/14/26 | 212.71 on 02/18/26 | 390.14 on 02/27/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 415,020 | 323,286,752 | 209,244,640 | 184,909,664 | 126,211,712 |
| Shares Outstanding, K | 54,039 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 2,370,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -62,810,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 680,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -33,750,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.90 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.63 on 11/05/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 03/11/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.73 | 17.76 | 18.28 | 30.26 |